Atenolol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for atenolol and what is the scope of freedom to operate?
Atenolol
is the generic ingredient in five branded drugs marketed by Astrazeneca, Able, Apothecon, Aurobindo Pharma, Chartwell Rx, Hlthcare, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, SCS, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Twi Pharms, Unichem, Unique, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, Aurobindo Pharma Usa, Novitium Pharma, and Zydus Pharms, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.There are thirty-four drug master file entries for atenolol. Thirty-three suppliers are listed for this compound.
Summary for atenolol
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 26 |
NDAs: | 42 |
Drug Master File Entries: | 34 |
Finished Product Suppliers / Packagers: | 33 |
Raw Ingredient (Bulk) Api Vendors: | 163 |
Clinical Trials: | 118 |
Patent Applications: | 6,575 |
Drug Prices: | Drug price trends for atenolol |
Drug Sales Revenues: | Drug sales revenues for atenolol |
What excipients (inactive ingredients) are in atenolol? | atenolol excipients list |
DailyMed Link: | atenolol at DailyMed |
Recent Clinical Trials for atenolol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Zagazig University | Phase 2 |
Ain Shams University | Phase 4 |
University of California, San Francisco | Phase 3 |
Pharmacology for atenolol
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for atenolol
Anatomical Therapeutic Chemical (ATC) Classes for atenolol
US Patents and Regulatory Information for atenolol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Twi Pharms | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 072302-002 | May 31, 1990 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hlthcare | ATENOLOL | atenolol | TABLET;ORAL | 073026-003 | Sep 17, 1991 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ipca Labs Ltd | ATENOLOL | atenolol | TABLET;ORAL | 077877-001 | Dec 27, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Scs | ATENOLOL | atenolol | TABLET;ORAL | 073676-001 | Oct 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Strides Pharma | ATENOLOL | atenolol | TABLET;ORAL | 073543-001 | Dec 19, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for atenolol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Twi Pharms | TENORMIN | atenolol | TABLET;ORAL | 018240-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Twi Pharms | TENORMIN | atenolol | TABLET;ORAL | 018240-004 | Apr 9, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Twi Pharms | TENORMIN | atenolol | TABLET;ORAL | 018240-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Twi Pharms | TENORMIN | atenolol | TABLET;ORAL | 018240-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Twi Pharms | TENORMIN | atenolol | TABLET;ORAL | 018240-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.